Home > Analytics > GLOBAL HEALTH

GLOBAL HEALTH
Intrinsic Value | Fundamental Analysis

BOM : 543654     NSE : MEDANTA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : NA
May 18,2024
Price(EOD): ₹ 1,405.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 37,745.73 Cr
Value of ₹ 1 Lac invested in GLOBAL HEALTH
on Nov 16,2022 (price: ₹ 415.65)

₹ 1 L

₹ 3.38 L

1W : -0.6% 1M : 2.5% 1Y : 147.8%
COMMUNITY POLL
for GLOBAL HEALTH
Please provide your vote to see the results
GLOBAL HEALTH is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
GLOBAL HEALTH -0.6% 2.5% 147.8%
APOLLO HOSPITALS ENTERPRISE 1.7% -1.8% 30.8%
MAX HEALTHCARE INSTITUTE 3.7% 9% 65.8%
FORTIS HEALTHCARE 1.7% 3.8% 63.8%
NARAYANA HRUDAYALAYA 3.5% 4.2% 71.1%
ASTER DM HEALTHCARE 0% -33.4% 37.2%
DR LAL PATHLABS 1.8% 13.1% 25.6%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 0.1% 0.2% 24.3%
RAINBOW CHILDRENS MEDICARE 2.9% 7.3% 47.3%

FUNDAMENTAL ANALYSIS OF GLOBAL HEALTH

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 MEDANTA is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF GLOBAL HEALTH

 
Valuation Score
[As on : May 18,2024 ]

Ratio Consolidated
P/E
P/B
P/S
78.96
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 478.06 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

12.99
P/B Calculated based on Book Value of Rs 2,905.63 Cr
[Latest Year - Mar2024 - Consolidated Results ]

11.59
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 3,258.21 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF GLOBAL HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
1817%
2162%
89%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GLOBAL HEALTH



GLOBAL HEALTH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GLOBAL HEALTH

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.04
0.07
0.02
0.04
0.35
0.52
0.48
0.45
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GLOBAL HEALTH

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GLOBAL HEALTH

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-2.88%
-15.44%
-16.99%
3.08%
14.37%
7.56%
7.52%
26%
QtrlyTrend
2
Latest Qtr: Mar2024
Quarterly Result Analysis →


GLOBAL HEALTH related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 5.9% 5.6% 61.1%
S&P BSE 250 SMALLCAP 5.7% 4.7% 58.4%
S&P BSE MIDSMALLCAP 5.2% 6.2% 62.2%
S&P BSE 400 MIDSMALLCAP 5.1% 6% 57.9%
S&P BSE ALLCAP 3.2% 3.6% 36.9%
NSE Indices1W1M1Y
NIFTY FREE SMALL 100 6.1% 4.1% 72%
NIFTY SMALLCAP250 5.9% 5% 64.7%
NIFTY MID SMALL400 5% 5.6% 60.2%
NIFTY500 MULTICAP 50:25:25 3.8% 4.2% 44.5%
NIFTY 500 3.1% 3.5% 36%

You may also like the below Video Courses


FAQ about GLOBAL HEALTH


Is GLOBAL HEALTH good for long term investment?

As on May 18,2024, the Fundamentals of GLOBAL HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of GLOBAL HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GLOBAL HEALTH UnderValued or OverValued?

As on May 18,2024, GLOBAL HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GLOBAL HEALTH ?

As on May 18,2024, the Intrinsic Value of GLOBAL HEALTH is Rs. 73.33 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 73.33
Fair Value [Median EV / Sales Model] : Rs. 62.15
Fair Value [Median Price / Sales Model] : Rs. 743.13
Estimated Median Fair Value of GLOBAL HEALTH : Rs. 73.33

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is GLOBAL HEALTH trading at a Premium or Discount?

As on May 18,2024, GLOBAL HEALTH is trading at a Premium of 1817% based on the estimates of Median Intrinsic Value!